Recent insider trading activity from Gerber Brianna, including buys and sells reported to the SEC.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 22, 2024 | Niagen Bioscience, Inc. | $NAGE | Gerber Brianna | Chief Financial Officer | A | Employee Stock Options (right to buy) | 213886 | $0.00 | 213,886.0000 | 74,985,000 | 9999.99% | 0.29% |